Searched for
CHLOPHENIRAMINE MALEATE
India bans 14 fixed-dose medicines for likely posing risks to healthThe Indian government has banned 14 types of fixed-dose combination (FDC) medicines due to a lack of therapeutic justification and potentia...
Govt bans 14 fixed dose combination drugs, cites they may involve risk to peopleThe expert committee said that there is "no therapeutic justification for this FDC (fixed dose combination) and the FDC may involve risk to...
Pfizer withdraws Corex syrup, extends line to new productsAccording to Pfizer, with this formulation, all additional line extensions will be introduced with all due regulatory approvals in place.
Drug makers body says government's ban 'arbitrary and unfair'Terming the decision to ban 344 fixed dose combination medicines as "arbitrary and unfair", pharma industry has said it feels let down by t...
40% doctors disagree with government's recent drug ban list: SurveyNearly 40 per cent of doctors disagreed with the government's move to ban 344 fixed dose combination drugs, a survey said.
Procter and Gamble to resume manufacturing, sale of Vicks Action 500 ExtraGovernment has banned medicines including Vicks Action 500 Extra as part of its decision to stop the manufacture and sale of fixed dose com...
Make names of banned drugs public: Congress MP to GovernmentCiting reports that household names like Corex and Vicks Action 500 have been banned, Shukla said people should know the names of all such ...
P&G stops selling Vicks Action 500 Extra in India after banP&G said all its products, including Vicks Action 500 Extra, were backed by research to support their quality, safety and efficacy.
Delhi High Court stays Corex ban on Pfizer’s petitionThe order is estimated to impact pharmaceutical brands worth Rs 3,800 crore sold in the Indian market, according to market research experts.
Pfizer, Abbott stop sale of cough syrups in India post banCorex is a combination of chlopheniramine maleate and codeine syrup - one of 344 drug combinations India banned over the weekend.